In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial

Published:1994-08 Issue:4 Volume:19 Page:235-243
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

D. Gootz Thomas,Brighty Katherine E.,Anderson Marge R.,Schmieder Brenda J.,Haskell Suzanne L.,Sutcliffe Joyce A.,Castaldi Michael J.,McGuirk Paul R.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference18 articles.

1. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches;Ball;J Antimicrob Chemother,1990

2. Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents;Barrett;Antimicrob Agents Chemother,1989

3. Activity in vitro of the quinolones;Eliopoulos,1993

4. In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of grampositive bacteria;Eliopoulos;Antimicrob Agents Chemother,1993

5. Antibiotic sensitivity testing: report of international collaborative study;Ericcson;Acta Pathol Microbiol Scand,1971

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Microbiology in the Development of New Antimicrobial Agents;Antimicrobial Susceptibility Testing Protocols;2007-05-22

2. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cellsin vitro;Journal of Orthopaedic Research;2000-09

3. Activities of Trovafloxacin Compared with Those of Other Fluoroquinolones against Purified Topoisomerases and gyrA and grlA Mutants of Staphylococcus aureus;Antimicrobial Agents and Chemotherapy;1999-08

4. Trovafloxacin: A New Fluoroquinolone;Annals of Pharmacotherapy;1999-01

5. Comparative in-vitro activities of trovafloxacin, ciproflaxacin, of loxacin, fleroxacin and broad-spectrum β-lactams against aerobe blood culture isolates;Zentralblatt für Bakteriologie;1998-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3